MDxHealth (NASDAQ:MDXH) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.19) by 26.32 percent. This is a 64.1 percent increase over losses of $(0.39) per share from the same period last year. The company reported quarterly sales of $24.74 million which beat the analyst consensus estimate of $23.36 million by 5.90 percent. This is a 27.53 percent increase over sales of $19.40 million the same period last year.